Topas Therapeutics Funding: $26M Raised, Series B (2018)
Topas Therapeutics is based in Hamburg, Germany. It has raised $26M in total funding. Latest round: Series B.
Topas Therapeutics funding overview
Topas Therapeutics is based in Hamburg, Germany. Topas Therapeutics has raised $26M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2018. The round record for Topas Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include Vesalius BioCapital III, BioMedPartners. 2 distinct backers are named across the disclosed rounds.
Topas Therapeutics at a glance
Total raised
$26M
Latest round
Series B
Latest round date
June 2018
Headquarters
Hamburg, Germany
Notable investors
Vesalius BioCapital III, BioMedPartners
Frequently asked about Topas Therapeutics funding
How much has Topas Therapeutics raised?
Topas Therapeutics has raised $26M in total disclosed funding across the rounds on record.
Who has invested in Topas Therapeutics?
Vesalius BioCapital III, BioMedPartners are named among the investors backing Topas Therapeutics.
What was the latest Topas Therapeutics funding round?
The most recent disclosed round is a Series B, announced in June 2018.
Where is Topas Therapeutics based?
Topas Therapeutics is based in Hamburg, Germany.
When did Topas Therapeutics last raise?
The last disclosed Topas Therapeutics round closed in June 2018 at Series B.
Topas Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hamburg below to benchmark round size and investor mix.
